Literature DB >> 5107390

"Refractory" thrombocytopenic purpura treated successfully with cyclophosphamide.

R K Laros, J A Penner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5107390

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Chronic idiopathic thrombocytopenic purpura. A case report.

Authors:  S K Kalra; V Vatwani; P K Sarkar; R Nath
Journal:  Indian J Pediatr       Date:  1977-11       Impact factor: 1.967

Review 2.  Immunosuppressant therapy of idiopathic thrombocytopenic purpura.

Authors:  Y S Ahn; W J Harrington; R Mylvaganam
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Cyclophosphamide and whole organ transplantation in human beings.

Authors:  T E Starzl; C W Putnam; C G Halgrimson; G T Schroter; G Martineau; B Launois; J L Corman; I Penn; A S Booth; C G Groth; K A Porter
Journal:  Surg Gynecol Obstet       Date:  1971-12

4.  Curculigo orchioides Gaertn Effectively Ameliorates the Uro- and Nephrotoxicities Induced by Cyclophosphamide Administration in Experimental Animals.

Authors:  Vishnu Priya Murali; Girija Kuttan
Journal:  Integr Cancer Ther       Date:  2015-09-29       Impact factor: 3.279

5.  In vivo protection by protein A of hepatic microsomal mixed function oxygenase system of cyclophosphamide-treated rats.

Authors:  M Dohadwala; P K Ray
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Low-dose vincristine in the treatment of corticosteroid-refractory idiopathic thrombocytopenic purpura (ITP) in non-splenectomized patients.

Authors:  F Cervantes; E Montserrat; C Rozman; C Diumenjo; E Feliu; A Grañena
Journal:  Postgrad Med J       Date:  1980-10       Impact factor: 2.401

7.  Clinical use of immunosuppressive drugs: part II.

Authors:  N L Gerber; A D Steinberg
Journal:  Drugs       Date:  1976       Impact factor: 9.546

8.  Intermittent cyclophosphamide treatment of autoimmune thombocytopenia.

Authors:  B Weinerman; I Maxwell; W Hryniuk
Journal:  Can Med Assoc J       Date:  1974-11-16       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.